Gold-Based Drugs for the Effective Treatment of Ovarian Cancer

This project will test new gold-based compounds as alternatives to current ovarian cancer chemotherapies using immunoassays and a novel immunocompetent ovarian cancer mouse model.

This scholarship will fund a 3-year PhD candidature working in the Cancer, Ageing & Vaccine Laboratory (SHBS). The project is a collaboration with chemists (SoS) to test gold compounds as anti-ovarian cancer therapeutics.

• The value of the scholarship is equivalent to an RMIT full scholarship
• This scholarship will be available for 3.5 years.

Applicants need to have a background in immunology or cancer biology, preferably cancer immunology and most preferably ovarian cancer. They must have completed a relevant Bachelors degree and Honours or Masters. Due to COVID-19 restrictions, applicants must be living in Australia at time of application.